Is Neoadjuvant Treatment Justified in Clinical T1 Pancreatic Ductal Adenocarcinoma?

Introduction: Studies on neoadjuvant treatment have been actively conducted in patients with resectable pancreatic cancer. However, neoadjuvant treatment effectiveness, especially in clinical T1 stage patients, still needs to be determined. We comparatively evaluated the oncologic benefit of preoper...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung Sun, Nakagawa, Kenji, Akahori, Takahiro, Nakamura, Kota, Takagi, Tadataka, Sho, Masayuki, Park, Joon Seong, Yoon, Dong Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924368/
https://www.ncbi.nlm.nih.gov/pubmed/33672686
http://dx.doi.org/10.3390/jcm10040873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924368/
https://www.ncbi.nlm.nih.gov/pubmed/33672686
http://dx.doi.org/10.3390/jcm10040873

Ejemplares similares